UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TET2 mutations in cytogenetically normal acute myeloid leukemia: Clinical implications and evolutionary patterns

Genes chromosomes & cancer, 2014-10, Vol.53 (10), p.824-832

2014

Volltextzugriff (PDF)

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy

Cancer medicine (Malden, MA), 2020-11, Vol.9 (22), p.8386-8396

2020

Volltextzugriff (PDF)

Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT

European journal of haematology, 2012-09, Vol.89 (3), p.214-219

2012

Volltextzugriff (PDF)

The Menin story in acute myeloid leukaemia—The road to success

British journal of haematology, 2024-09, Vol.205 (3), p.812-814

2024

Volltextzugriff (PDF)

AML in the elderly—A global view

British journal of haematology, 2023-12, Vol.203 (5), p.760-773

2023

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

British journal of haematology, 2021-11, Vol.195 (3), p.417-428

2021

Volltextzugriff (PDF)

A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

British journal of haematology, 2015-06, Vol.169 (5), p.694-700

2015

Volltextzugriff (PDF)

A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

British journal of haematology, 2020-08, Vol.190 (3), p.e169-e173

2020

Volltextzugriff (PDF)

Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche

British journal of haematology, 2022-07, Vol.198 (1), p.114-130

2022

Volltextzugriff (PDF)

Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia

British journal of haematology, 2021-05, Vol.193 (3), p.592-601

2021

Volltextzugriff (PDF)

FLA‐IDA salvage chemotherapy combined with a seven‐day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia

British journal of haematology, 2020-02, Vol.188 (3), p.e11-e15

2020

Volltextzugriff (PDF)

Alloantigen-specific de novo-induced Foxp3⁺ Treg revert in vivo and do not protect from experimental GVHD

European journal of immunology, 2009-11, Vol.39 (11), p.3091-3096

2009

Volltextzugriff (PDF)

Sequential chemotherapy followed by reduced‐intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT

British journal of haematology, 2017-02, Vol.176 (3), p.431-439

2017

Volltextzugriff (PDF)

Effects of pharmacological intervention on coagulopathy and organ function in xenoperfused kidneys

Xenotransplantation (Københaven), 2008-02, Vol.15 (1), p.46-55

2008

Volltextzugriff (PDF)

Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations

Genes chromosomes & cancer, 2012-07, Vol.51 (7), p.689-695

2012

Volltextzugriff (PDF)

Centre characteristics and procedure‐related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)

British journal of haematology, 2017-08, Vol.178 (4), p.521-533

2017

Volltextzugriff (PDF)

Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group

American journal of hematology, 2020-07, Vol.95 (7), p.809-816

2020

Volltextzugriff (PDF)

Treating acute promyelocytic leukaemia in Latin America: lessons from the International Consortium on Acute Leukaemia experience

British journal of haematology, 2017-06, Vol.177 (6), p.979-983

2017

Volltextzugriff (PDF)

Letter to the Editor: Production of Mature Healthy Hematopoietic Cells from Induced Pluripotent Stem Cells Derived from an AML Diagnostic Sample Containing the t(8;21) Translocation

Stem cells (Dayton, Ohio), 2016-03, Vol.34 (3), p.797-799

2016

Volltextzugriff (PDF)

Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome

European journal of haematology, 2012-01, Vol.88 (1), p.52-60

2012

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(69)
Reviews
(2)
Berichte
(1)

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Humans
(48)
Hematology
(44)
Male
(32)
Adult
(31)
Female
(28)
Middle Aged
(28)
Aged
(22)
Biological And Medical Sciences
(17)
Medical Sciences
(16)
Leukemia
(15)
Acute Myeloid Leukaemia
(11)
Acute Myeloid Leukemia
(11)
Adolescent
(11)
Leukemia, Myeloid, Acute - Genetics
(11)
Oncology
(11)
Retrospective Studies
(10)
Stem Cell Transplantation
(10)
Chemotherapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

TET2 mutations in cytogenetically normal acute myeloid leukemia: Clinical implications and evolutionary patterns

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy

Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT

The Menin story in acute myeloid leukaemia—The road to success

AML in the elderly—A global view

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche

Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia

FLA‐IDA salvage chemotherapy combined with a seven‐day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia

Alloantigen-specific de novo-induced Foxp3⁺ Treg revert in vivo and do not protect from experimental GVHD

Sequential chemotherapy followed by reduced‐intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT

Effects of pharmacological intervention on coagulopathy and organ function in xenoperfused kidneys

Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT

Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations

Centre characteristics and procedure‐related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)

Outcome of patients with Fanconi anemia developing myelodysplasia and acute leukemia who received allogeneic hematopoietic stem cell transplantation: A retrospective analysis on behalf of EBMT group

Treating acute promyelocytic leukaemia in Latin America: lessons from the International Consortium on Acute Leukaemia experience

Letter to the Editor: Production of Mature Healthy Hematopoietic Cells from Induced Pluripotent Stem Cells Derived from an AML Diagnostic Sample Containing the t(8;21) Translocation

The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT)

Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome

Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine

Aktive Filter

Suchergebnisse filtern